Clinical Trial Update: Obese Patients With Untreated Dyslipidemias [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in obese patients with untreated dyslipidemias has completed. No efficacy results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Obesity

Snippet

Sponsor: Sanofi | Conditions: Obesity, Dyslipidemia | Phase 3 | Status: COMPLETED